Chain Drug Review recently highlighted SpecialtyRx's continued national expansion following the company's announcement that it now serves more than 350,000 patients annually across 1,150 healthcare facilities in 18 states.
The article recognizes SpecialtyRx's rapid growth over the past several years, including the expansion from three pharmacy locations in 2021 to 15 full-service pharmacies today. It also highlights the company's role in supporting skilled nursing facilities, assisted living communities, rehabilitation centers, and other long-term care providers with reliable pharmacy services and technology-driven solutions.
As healthcare providers continue to navigate staffing shortages, increasing patient complexity, and evolving regulatory requirements, the article notes SpecialtyRx's ongoing investment in pharmacy technology designed to improve medication management, streamline workflows, and support better operational efficiency. The coverage also emphasizes the company's commitment to maintaining personalized service while expanding its national footprint.
The feature includes perspectives from SpecialtyRx founders Joel Zupnick and Chesky Berkowitz, who discuss the importance of earning provider trust, scaling responsibly, and continuing to invest in solutions that help long-term care organizations deliver exceptional patient care.
Being recognized by a leading pharmacy industry publication reflects SpecialtyRx's continued momentum and reinforces the company's commitment to helping long-term care providers meet the evolving needs of their residents through dependable pharmacy partnership and innovation.
